-
In late February 2026, Vital Farms reported fourth-quarter and full-year 2025 results showing higher sales and net income year over year, while also lowering its 2026 revenue outlook to US$900 million–US$920 million amid macroeconomic volatility and softer early-year orders.
-
On the same day, founder Matt O'Hayer stepped down from the Board and Russell Diez-Canseco was named Executive Chairperson, consolidating leadership as the company invests heavily to expand its pasture-raised egg and butter supply chain.
-
We'll now examine how the earnings miss and reduced 2026 guidance affect Vital Farms' previously optimistic investment narrative and growth assumptions.
Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
Vital Farms Investment Narrative Recap
To stay invested in Vital Farms, you need to believe its pasture raised brand, expanded farm network, and new capacity can translate into profitable growth despite near term volatility. The key short term catalyst is whether 2026 revenue and EBITDA can meet the lowered outlook after the recent guidance reset and earnings miss, while the biggest risk is that heavy capital spending and promotions weigh on margins if demand or order patterns remain choppy.
The most relevant update here is the reduced 2026 revenue guidance to US$900 million to US$920 million, which sits below prior expectations and triggered a sharp share price reaction. This shift directly tests the earlier growth thesis that new facilities and farm expansion would unlock strong, volume led gains without meaningfully compressing profitability, and it puts more pressure on management to prove that recent order volatility is temporary rather than a sign of weaker category momentum.
But while guidance still implies growth, investors should be aware that heavier promotion, volatile orders, and rising fixed costs could all converge if...
Read the full narrative on Vital Farms (it's free!)
Vital Farms' narrative projects $1.2 billion revenue and $103.0 million earnings by 2028. This requires 22.5% yearly revenue growth and a $51.4 million earnings increase from $51.6 million today.
Uncover how Vital Farms' forecasts yield a $49.45 fair value , a 146% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were assuming revenue could reach about US$1.4 billion and earnings US$97 million by 2029, a far steeper path than consensus, which shows how differently you might weigh the recent guidance cut against the idea that capacity additions and stronger animal welfare trends can still support a much faster growth story.
Explore 8 other fair value estimates on Vital Farms - why the stock might be worth just $31.00!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
-
A great starting point for your Vital Farms research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
-
Our free Vital Farms research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Vital Farms' overall financial health at a glance.
Seeking Other Investments?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
-
AI is about to change healthcare. These 28 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early.
-
Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.
-
The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include VITL .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
